ロード中...
Clinical Evaluation of TRICOM Vector Therapeutic Cancer Vaccines
We have developed an “off-the-shelf” vector-based vaccine platform containing transgenes for carcinoma-associated antigens and multiple costimulatory molecules (designated TRICOM). Two TRICOM platforms have been evaluated both preclinically and in clinical trials. PROSTVAC consists of rV, rF-PSA-TRI...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3398615/ https://ncbi.nlm.nih.gov/pubmed/22595052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2012.02.010 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|